Incidence and feasibility of coronary access after transcatheter aortic valve replacement

被引:61
作者
Nai Fovino, Luca [1 ]
Scotti, Andrea [1 ]
Massussi, Mauro [1 ]
Fabris, Tommaso [1 ]
Cardaioli, Francesco [1 ]
Rodino, Giulio [1 ]
Matsuda, Yuji [1 ]
Frigo, Francesca [1 ]
Fraccaro, Chiara [1 ]
Tarantini, Giuseppe [1 ]
机构
[1] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Sch Med, Via Giustiniani 2, I-35128 Padua, Italy
关键词
coronary access; coronary artery disease; percutaneous coronary intervention; transcatheter aortic valve replacement; IMPLANTATION; INTERVENTION; ANGIOGRAPHY; MANAGEMENT; OUTCOMES; DISEASE; TAVR;
D O I
10.1002/ccd.28720
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Incidence of coronary access (CA) after transcatheter aortic valve replacement (TAVR) at long-term follow-up remains unknown. CA and percutaneous coronary intervention (PCI) after TAVR might present technical challenges, particularly with supra-annular devices. Methods Patients undergoing CA after being treated with TAVR at our institution were included in the study. Coronary interventions for coronary obstruction during TAVR procedure were excluded. Incidence, feasibility and outcomes of CA after TAVR were analyzed. Results Out of 912 patients aged 80 +/- 7 years treated with TAVR at our institution between 2007 and 2018, 48 (5.3%) underwent CA at a median follow up of 769 [363-1,471] days. Twenty-one had received a SAPIEN XT, 15 a SAPIEN 3, 6 Corevalve, 2 Evolut Pro, 2 JenaValve, and 2 Lotus valve. PCI was indicated in 26 (54%) cases. Seventeen (35%) procedures were performed for acute coronary syndromes (ACS). Independent predictors of CA after TAVR were younger age, previous PCI, and CABG. CA of both vessels was feasible in all patients with an intra-annular device, while the right coronary artery was not engaged in two patients with a supra-annular valve. PCI was successful in all but one case. All-cause mortality was similar between patients needing CA for ACS and those who had other clinical indications. Conclusions In this high-risk AS population, incidence of CA after TAVR at long-term follow-up was rather low. CA and PCI were safe and successful in most cases, with a lower rate of selective CA for supra-annular devices.
引用
收藏
页码:E535 / E541
页数:7
相关论文
共 28 条
[1]   Incidence, feasibility and outcome of percutaneous coronary intervention after transcatheter aortic valve implantation with a self-expanding prosthesis. Results from a single center experience [J].
Allali, Abdelhakim ;
El-Mawardy, Mohamed ;
Schwarz, Bettina ;
Sato, Takao ;
Geist, Volker ;
Toelg, Ralph ;
Richardt, Gert ;
Abdel-Wahab, Mohamed .
CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2016, 17 (06) :391-398
[2]  
Baumgartner H, 2018, EUR HEART J, V39, P1980, DOI [10.1093/eurheartj/ehx636, 10.1093/eurheartj/ehx391]
[3]   Challenges of coronary angiography and intervention in patients previously treated by TAVI [J].
Blumenstein, Johannes ;
Kim, Won-Keun ;
Liebetrau, Christoph ;
Gaede, Luise ;
Kempfert, Joerg ;
Walther, Thomas ;
Hamm, Christian ;
Moellmann, Helge .
CLINICAL RESEARCH IN CARDIOLOGY, 2015, 104 (08) :632-639
[4]   Coronary Procedures After TAVI With the Self-Expanding Aortic Bioprosthesis Medtronic CoreValve™, Not an Easy Matter [J].
Boukantar, Madjid ;
Gallet, Romain ;
Mouillet, Gauthier ;
Belarbi, Abdelkaoui ;
Rubimbura, Vladimir ;
Ternacle, Julien ;
Dubois-Rande, Jean-Luc ;
Teiger, Emmanuel .
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2017, 30 (01) :56-62
[5]   Independent impact of extent of coronary artery disease and percutaneous revascularization on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results [J].
D'Ascenzo, Fabrizio ;
Verardi, Roberto ;
Visconti, Massimiliano ;
Conrotto, Federico ;
Scacciatella, Paolo ;
Dziewierz, Artur ;
Stefanini, Giulio G. ;
Paradis, Jean-Michel ;
Omede, Pierluigi ;
Kodali, Susheel ;
D'Amico, Maurizio ;
Rinaldi, Mauro ;
Salizzoni, Stefano .
EUROINTERVENTION, 2018, 14 (11) :E1169-E1177
[6]   Coronary Artery Disease and Transcatheter Aortic Valve Replacement JACC State-of-the-Art Review [J].
Faroux, Laurent ;
Guimaraes, Leonardo ;
Wintzer-Wehekind, Jerome ;
Junquera, Lucia ;
Ferreira-Neto, Alfredo Nunes ;
del Val, David ;
Muntane-Carol, Guillem ;
Mohammadi, Siamak ;
Paradis, Jean-Michel ;
Rodes-Cabau, Josep .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (03) :362-372
[7]   Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve [J].
Fovino, Luca Nai ;
Badawy, Mostafa R. A. ;
Fraccaro, Chiara ;
D'Onofrio, Augusto ;
Purita, Paola A. M. ;
Frigo, Anna C. ;
Tellaroli, Paola ;
Mauro, Agnifili ;
Tusa, Maurizio ;
Napodano, Massimo ;
Gerosa, Gino ;
Iliceto, Sabino ;
Bedogni, Francesco ;
AbdelRheim, Alaa E. R. ;
Tarantini, Giuseppe .
JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (11) :655-663
[8]   Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic self-expandable bioprosthetic valve [J].
Htun, Wah Wah ;
Grines, Cindy ;
Schreiber, Theodore .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 91 (07) :1339-1344
[9]   Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document [J].
Kappetein, A. Pieter ;
Head, Stuart J. ;
Genereux, Philippe ;
Piazza, Nicolo ;
van Mieghem, Nicolas M. ;
Blackstone, Eugene H. ;
Brott, Thomas G. ;
Cohen, David J. ;
Cutlip, Donald E. ;
van Es, Gerrit-Anne ;
Hahn, Rebecca T. ;
Kirtane, Ajay J. ;
Krucoff, Mitchell W. ;
Kodali, Susheel ;
Mack, Michael J. ;
Mehran, Roxana ;
Rodes-Cabau, Josep ;
Vranckx, Pascal ;
Webb, John G. ;
Windecker, Stephan ;
Serruys, Patrick W. ;
Leon, Martin B. .
EUROPEAN HEART JOURNAL, 2012, 33 (19) :2403-+
[10]  
Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI [10.1016/j.jacc.2014.02.536, 10.1016/j.jacc.2014.02.537, 10.1016/j.jtcvs.2014.05.014]